About Index Trending news
Analyze
Pricing
Esperion Therapeutics

Esperion Therapeutics

Work at Esperion Therapeutics? Add yourself to this profile

Esperion Therapeutics

Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Edit Profile
More info

Elsewhere

Companies in the same industry

Prexton Therapeutics SA Prexton Therapeutics SA Ritter Pharmaceuticals, Inc. Ritter Pharmaceuticals, Inc. eXIthera Pharmaceuticals eXIthera Pharmaceuticals BioFab BioFab Bioquark Inc. Bioquark Inc. Provia Laboratories Provia Laboratories Prospective Research Prospective Research Pearl Therapeutics Pearl Therapeutics Pfizer Inc. Pfizer Inc. Amplyx Pharmaceuticals, Inc Amplyx Pharmaceuticals, Inc

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Latest funding Show all
Post-IPO equity
$189,900,000
Venture capital
$33,000,000
Employees

Team size

10+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Esperion Therapeutics makes some noise.